Order Article Reprints

Załęski A, Lembas A, Dyda T, Osińska J, Jabłońska J, Stempkowska-Rejek J, Orzechowska J, Wiercińska-Drapało A. Drug Resistance Mutations (DRMs) for Long-Acting Injectable Cabotegravir and Rilpivirine (CAB/RPV LAI) in the HIV-1 Subtype A6 Epidemic in Poland. Microorganisms. 2025; 13(2):321. https://doi.org/10.3390/microorganisms13020321

Załęski, Andrzej, Agnieszka Lembas, Tomasz Dyda, Joanna Osińska, Joanna Jabłońska, Justyna Stempkowska-Rejek, Justyna Orzechowska, and Alicja Wiercińska-Drapało. 2025. "Drug Resistance Mutations (DRMs) for Long-Acting Injectable Cabotegravir and Rilpivirine (CAB/RPV LAI) in the HIV-1 Subtype A6 Epidemic in Poland" Microorganisms 13, no. 2: 321. https://doi.org/10.3390/microorganisms13020321

Załęski, A., Lembas, A., Dyda, T., Osińska, J., Jabłońska, J., Stempkowska-Rejek, J., Orzechowska, J., & Wiercińska-Drapało, A. (2025). Drug Resistance Mutations (DRMs) for Long-Acting Injectable Cabotegravir and Rilpivirine (CAB/RPV LAI) in the HIV-1 Subtype A6 Epidemic in Poland. Microorganisms, 13(2), 321. https://doi.org/10.3390/microorganisms13020321